Marine-Derived Fungal Metabolite MHO7 Promotes Breast Cancer Apoptosis as a Hippo Pathway Regulator by Modulating the YAP-TEAD Axis
Marine Drugs · 2026
DOI: 10.3390/md24080273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2026. Verfasst von Xue Ren und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Medical Oncology (Gynecological Cancers), Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan…. Hauptthemen laut MEDLINE: Apoptosis, Breast Neoplasms, Antineoplastic Agents, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Breast cancer, especially triple-negative breast cancer (TNBC) and endocrine-resistant disease, remains difficult to treat because of limited effective targeted therapies. In this study, we evaluated the antitumor activity and potential mechanism of MHO7, a marine-derived ophiobolin metabolite, in ER-positive ZR-75-30 cells, tamoxifen-resistant LCC2 cells, and TNBC MDA-MB-231 models. MHO7 dose-dependently reduced cell viability, wound closure, and clonogenic growth in ZR-75-30 and LCC2 cells, with IC50 values of 11.53 and 10.43 μM, respectively. MHO7 also promoted apoptotic cell death, accompanied by increased reactive oxygen species accumulation and altered expression of apoptosis-related proteins, including Bcl-2 and caspase-3. N-acetyl-L-cysteine partially attenuated MHO7-induced apoptosis and YAP reduction in MDA-MB-231 cells, suggesting a contribution of oxidative stress. Molecular docking predicted that MHO7 could occupy the conserved TEAD palmitoylation pocket, and subsequent in vitro analyses showed suppression of YAP/TAZ-TEAD signaling, including reduced YAP nuclear accumulation and decreased TEAD4 expression. In an MDA-MB-231 xenograft model, MHO7 significantly inhibited tumor growth, reduced CD31-positive microvessel density, and decreased Hippo pathway-related transcriptional readouts. These findings indicate that MHO7 exerts broad antitumor activity in breast cancer models through oxidative stress-associated apoptosis and modulation of YAP/TAZ-TEAD signaling, supporting its further development as a lead compound for treatment-resistant breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation and Medical Oncology (Gynecological Cancers), Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430072, China.
- The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ren, X., Wang, L., Huang, Y., Shu, B., Hou, K., Chen, M., Xiao, Y., Liang, J., Yan, H., Ding, S., Qiu, H., Lu, J., Hong, K., & Liu, X. (2026). Marine-Derived Fungal Metabolite MHO7 Promotes Breast Cancer Apoptosis as a Hippo Pathway Regulator by Modulating the YAP-TEAD Axis. Marine Drugs. https://doi.org/10.3390/md24080273
Vancouver
Ren X, Wang L, Huang Y, Shu B, Hou K, Chen M, et al. Marine-Derived Fungal Metabolite MHO7 Promotes Breast Cancer Apoptosis as a Hippo Pathway Regulator by Modulating the YAP-TEAD Axis. Marine Drugs. 2026. doi:10.3390/md24080273
BibTeX
@article{Ren2026,
author = {Ren, Xue and Wang, Linfei and Huang, Yuxuan and Shu, Bei and Hou, Kerui and Chen, Mengyao and Xiao, Yao and Liang, Jiahong and Yan, Hao and Ding, Shuaishuai and Qiu, Hui and Lu, Jin and Hong, Kui and Liu, Xin},
title = {Marine-Derived Fungal Metabolite MHO7 Promotes Breast Cancer Apoptosis as a Hippo Pathway Regulator by Modulating the YAP-TEAD Axis},
journal = {Marine Drugs},
year = {2026},
doi = {10.3390/md24080273}
}
EUVIMED